Add this blogBaxter Delays PharMEDium Acquisition After Meningitis Outbreak
Baxter International has placed its acquisition of PharMEDium Healthcare Corp. on hold following the nationwide meningitis outbreak, according to LBO Wire, a part of Dow Jones.
The outbreak has been tied by the Centers for Disease Control and Prevention and the Food and Drug Administration to New England Compounding Center.
While PharMEDium, which is backed by Oak Investment Partners and Baird Private Equity, has not been linked to any of the meningitis cases, the outbreak created enough uncertainty concerning the safety of compounding companies to delay Baxter's planned acquisition, according to a Crain's report.
Amber Walsh is a partner with McGuireWoods LLP focusing on healthcare transactional work and regulatory matters. Her experience includes representation
As a partner with the firm, Geoff has a wide scope of expertise spanning mergers and acquisitions, senior and